← 產業報告目錄

Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2025-02-12頁數 512報告編號 BT3379

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global cell counting market is projected to surpass USD 16.14 billion in 2029 from USD 11.12 billion in 2024, with a significant CAGR of 7.7%. The market is growing at a significant CAGR owing to the adoption of fluorescence-based methods, offering enhanced sensitivity and specificity. Furthermore, the expanding focus on drug discovery, stem cell research, and regenerative medicine has amplified the demand for precise cell counting technologies across academic, clinical, and industrial settings. “Consumables dominated the products segment” Based on product the market is segmented into consumables and instruments. The consumables segment is further divided into media, sera & reagents, assay kits, microplates, accessories, and others. Instruments are further segmented into spectrophotometers, flow cytometers, hematology analyzers, cell counters, microscopes, and others. The launch of technologically advanced instruments is projecting the growth of the instruments segment. For instance, in September 2024, Logos Biosystems launched LUNA-III automated cell counter for bright field cell counting. “Medical application segment is anticipated grow at great pace ” The application segment is divided into research applications, medical applications, and bioproduction and quality control. Research applications is further divided into cancer research, immunology research, neurology research, stem cell research and other research applications. Medical applications is further segmented into hematology & complete blood count (CBC), non-invasive prenatal diagnostics, in vitro fertilization, circulating tumor cell detection, and other medical applications. Research applications segment dominated the market. Medical applications segment growing at a significant CAGR owing the increasing use of cell counting technologies in clinical diagnostics, personalized medicine, and treatment monitoring. “Academic & Research Institute dominated the segment” Based on the end users, the market is segmented into academic & research institutes, hospitals & diagnostics laboratories, pharmaceutical & biotechnology companies, and CROs & CDMOS. Academic & research institutes dominated the segment in 2023. Research institutions drive demand for reliable and accurate cell counting technologies to support a wide range of research applications. Extensive use of cell counting in laboratory settings, coupled with significant funding from both government and private sectors, further strengthens segments leadership in this market segment. “North America: the largest share of the cell counting market” The market is segmented by region into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America dominated the cell counting market in 2023 and is estimated to continue dominance during the forecast period. US leads the North American market, driven by the significant investment in biotechnology, and the presence of leading academic and research institutions. The country’s focus on innovative medical research, personalized healthcare, and precision medicine further bolsters its leadership in the market. European cell counting market is experiencing steady growth, supported by increasing research and development activities, especially in countries like Germany, the UK, and France. In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the cell counting market. The primary interviews conducted for this report can be categorized as follows: • By Respondent: Supply Side- 65% and Demand Side 35% • By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25% • By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5% Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGAA, Bio-Rad Laboratories, Inc., are some of the major players operating in the cell counting market. Research Coverage: This research report categorizes the cell counting market report is segmented based on products (consumables {media, sera & reagents, assay kits, microplates, accessories, and others} instruments (spectrophotometers {single-mode readers and multi-mode readers}, flow cytometers, hematology analyzers {fully automated and semi-automated}, cell counters {by mode [automated and manual] and technique [Fluorescence-Based Cell Counters, Image-Based Cell Counters, Brightfield Cell Counters, and Other Cell Counters, microscopes, and others]. Applications ( research applications {cancer research, immunology research, neurology research, stem cell research and other research applications}, medical applications {hematology & complete blood count (CBC), non-invasive prenatal diagnostics, in vitro fertilization, circulating tumor cell detection, and other medical applications}, and bioproduction and quality control}), end users (academic & research institutes, hospitals & diagnostics laboratories, pharmaceutical & biotechnology companies and CROs & CDMOs).The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell counting market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the cell counting market. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the cell counting and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights on the following pointers: • Analysis of key drivers (Technological Advancements, Increasing Research Activities, Expanding Applications in Diagnostics), restraints (High Initial Investment Costs), opportunities (Integration with Advanced Technologies, Personalized Medicine and Cell Therapy) and Challenges (Lack o Data Standardization) influencing the growth of the market. • Product Development/Innovation: Detailed insights on upcoming technologies in cell counting manufacturing, research and development activities, and new product launches in the cell counting market. • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell counting market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players Danaher Corporation, Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck KGAA and Bio-Rad Laboratories, Inc., among others.
目錄 Table of Contents
1 INTRODUCTION 46 1.1 STUDY OBJECTIVES 46 1.2 MARKET DEFINITION 46 1.3 STUDY SCOPE 47 1.3.1 MARKETS COVERED 47 1.3.2 REGIONAL SCOPE 48 1.3.3 INCLUSIONS & EXCLUSIONS 48 1.3.4 YEARS CONSIDERED 49 1.3.5 CURRENCY CONSIDERED 49 1.4 STAKEHOLDERS 49 1.5 SUMMARY OF CHANGES 50 2 RESEARCH METHODOLOGY 51 2.1 RESEARCH DATA 51 2.1.1 SECONDARY RESEARCH 52 2.1.2 PRIMARY RESEARCH 52 2.1.2.1 Key industry insights 54 2.2 MARKET SIZE ESTIMATION 54 2.2.1 GLOBAL MARKET ESTIMATION 55 2.2.1.1 Approach 1: Company revenue analysis (bottom-up approach) 55 2.2.1.2 Approach 2: MNM repository analysis 56 2.2.1.3 Approach 3: Primary interviews 56 2.2.2 SEGMENTAL MARKET ESTIMATION 57 2.2.2.1 Top-down approach 57 2.3 MARKET GROWTH RATE PROJECTIONS 58 2.4 DATA TRIANGULATION 60 2.5 RESEARCH ASSUMPTIONS 61 2.6 RESEARCH LIMITATIONS 62 2.7 RISK ANALYSIS 62 3 EXECUTIVE SUMMARY 63 4 PREMIUM INSIGHTS 66 4.1 CELL COUNTING MARKET OVERVIEW 66 4.2 NORTH AMERICA: CELL COUNTING MARKET, BY APPLICATION AND COUNTRY, 2023 67 4.3 CELL COUNTING MARKET, BY END USER, 2024 VS. 2029 67 4.4 CELL COUNTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 68   5 MARKET OVERVIEW 69 5.1 INTRODUCTION 69 5.2 MARKET DYNAMICS 69 5.2.1 DRIVERS 70 5.2.1.1 Technological advancements 70 5.2.1.2 Expanding applications in research and diagnostics 71 5.2.1.3 Rise in personalized medicine 71 5.2.2 RESTRAINTS 72 5.2.2.1 High cost of advanced systems 72 5.2.3 OPPORTUNITIES 72 5.2.3.1 Advancements in stem cell research 72 5.2.3.2 Rising demand for point-of-care diagnostics 72 5.2.4 CHALLENGES 73 5.2.4.1 Regulatory and compliance challenges 73 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73 5.4 PRICING ANALYSIS 74 5.4.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 74 5.4.2 AVERAGE SELLING PRICE TREND, BY REGION 76 5.5 SUPPLY CHAIN ANALYSIS 78 5.6 VALUE CHAIN ANALYSIS 79 5.7 ECOSYSTEM ANALYSIS 82 5.7.1 CELL COUNTING MARKET: RAW MATERIAL PROVIDERS 82 5.7.2 CELL COUNTING MARKET: PRODUCT MANUFACTURERS/PROVIDERS 83 5.7.3 CELL COUNTING MARKET: END USERS 83 5.7.4 CELL COUNTING MARKET: REGULATORY BODIES 84 5.8 INVESTMENT & FUNDING SCENARIO 84 5.9 TECHNOLOGY ANALYSIS 85 5.9.1 KEY TECHNOLOGIES 85 5.9.1.1 Automated cell counting 85 5.9.1.2 Flow cytometry 85 5.9.1.3 Image-based cell counting 86 5.9.2 COMPLEMENTARY TECHNOLOGIES 86 5.9.2.1 Cell culture 86 5.9.2.2 Centrifugation 86 5.9.2.3 Cell viability testing 86 5.9.3 ADJACENT TECHNOLOGIES 87 5.9.3.1 Genomic sequencing 87 5.9.3.2 Polymerase chain reaction (PCR) 87 5.9.3.3 Tissue engineering 87   5.10 PATENT ANALYSIS 88 5.11 TRADE ANALYSIS 90 5.11.1 TRADE DATA FOR FLOW CYTOMETERS 90 5.11.1.1 Import data for flow cytometers 90 5.11.1.2 Export data for flow cytometers 92 5.12 KEY CONFERENCES & EVENTS, 2025–2026 93 5.13 REGULATORY LANDSCAPE 94 5.13.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 5.13.2 REGULATORY FRAMEWORK 96 5.13.2.1 North America 96 5.13.2.2 Europe 96 5.13.2.3 Asia Pacific 97 5.14 PORTER’S FIVE FORCES ANALYSIS 97 5.14.1 THREAT OF NEW ENTRANTS 98 5.14.2 BARGAINING POWER OF SUPPLIERS 98 5.14.3 BARGAINING POWER OF BUYERS 99 5.14.4 THREAT OF SUBSTITUTES 99 5.14.5 INTENSITY OF COMPETITIVE RIVALRY 99 5.15 KEY STAKEHOLDERS & BUYING CRITERIA 99 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS 100 5.15.2 BUYING CRITERIA 101 5.16 IMPACT OF AI/GENERATIVE AI ON CELL COUNTING MARKET 102 5.16.1 INTRODUCTION 102 5.16.2 IMPACT OF AI ON CELL COUNTING ECOSYSTEM 103 5.16.3 FUTURE OF GENERATIVE AI IN CELL COUNTING ECOSYSTEM 104 6 CELL COUNTING MARKET, BY PRODUCT 105 6.1 INTRODUCTION 106 6.2 CONSUMABLES 106 6.2.1 MEDIA, SERA, AND REAGENTS 110 6.2.1.1 Rising demand for buffers & solvents in research & diagnostics to drive market 110 6.2.2 ASSAY KITS 113 6.2.2.1 Cell viability assays 116 6.2.2.1.1 Critical evaluation of cytotoxicity to drive segment growth 116 6.2.2.2 Cell staining assays 119 6.2.2.2.1 Advancements in imaging systems and flow cytometry to boost demand 119 6.2.2.3 Cytotoxicity assays 122 6.2.2.3.1 Provision of insights into cell viability & membrane integrity to fuel uptake 122   6.2.2.4 Calorimetric assays 125 6.2.2.4.1 Assessment of biochemical reactions to drive segment growth 125 6.2.2.5 Other assays 128 6.2.3 MICROPLATES 131 6.2.3.1 Rising utilization in high-throughput research to drive market 131 6.2.4 ACCESSORIES 134 6.2.4.1 Increasing demand for essential components like sensors & electrical accessories to support market growth 134 6.2.5 OTHER CONSUMABLES 137 6.3 INSTRUMENTS 139 6.3.1 SPECTROPHOTOMETERS 142 6.3.1.1 Single-mode readers 145 6.3.1.1.1 Wide utilization across research & industrial labs to boost demand 145 6.3.1.2 Multi-mode readers 148 6.3.1.2.1 Advanced data visualization software to support segment growth 148 6.3.2 FLOW CYTOMETERS 151 6.3.2.1 Wide uptake in clinical & research applications to propel market 151 6.3.3 HEMATOLOGY ANALYZERS 153 6.3.3.1 Fully automated Analyzers 156 6.3.3.1.1 High yield with minimal manual intervention to drive segment growth 156 6.3.3.2 Semi-automated Analyzers 159 6.3.3.2.1 Cost-efficiency and compact size to fuel uptake 159 6.3.4 CELL COUNTERS 162 6.3.4.1 Cell Counters, by mode 164 6.3.4.1.1 Automated cell counters 165 6.3.4.1.1.1 Reliable and rapid results to boost demand 165 6.3.4.1.2 Manual cell counters 168 6.3.4.1.2.1 High accuracy to support segment growth 168 6.3.4.2 Cell Counters, by technique 170 6.3.4.2.1 Fluorescence-based cell counters 171 6.3.4.2.1.1 Precise quantification of cell populations to drive segment growth 171 6.3.4.2.2 Image-based cell counters 174 6.3.4.2.2.1 Integration of image-based systems into laboratory workflows to fuel uptake 174 6.3.4.2.3 Brightfield cell counters 177 6.3.4.2.3.1 Increasing demand for efficient and cost-effective cell counting solutions to boost demand 177 6.3.4.2.4 Other cell counters 179   6.3.5 MICROSCOPES 182 6.3.5.1 Advancements in cell-based therapies to drive market 182 6.3.6 OTHER INSTRUMENTS 185 7 CELL COUNTING MARKET, BY APPLICATION 188 7.1 INTRODUCTION 189 7.2 RESEARCH APPLICATIONS 189 7.2.1 CANCER RESEARCH 193 7.2.1.1 Rising prevalence of cancer and growing focus on early detection to drive market 193 7.2.2 IMMUNOLOGY RESEARCH 197 7.2.2.1 Rising prevalence of autoimmune diseases to fuel market 197 7.2.3 NEUROLOGY RESEARCH 199 7.2.3.1 Rising incidence of neurological disorders to propel market 199 7.2.4 STEM CELL RESEARCH 202 7.2.4.1 Favorable R&D investments to boost demand 202 7.2.5 OTHER RESEARCH APPLICATIONS 205 7.3 MEDICAL APPLICATIONS 208 7.3.1 HEMATOLOGY & COMPLETE BLOOD COUNT 211 7.3.1.1 Uptake of hematology analyzers in diagnosis of anemia & leukemia to drive market 211 7.3.2 NON-INVASIVE PRENATAL DIAGNOSTICS 214 7.3.2.1 Provision of critical insights into fetal health to support market growth 214 7.3.3 IN VITRO FERTILIZATION 217 7.3.3.1 Increasing prevalence of infertility and advancements in assisted reproductive technologies to drive market 217 7.3.4 CIRCULATING TUMOR CELL DETECTION 219 7.3.4.1 Growing focus on precision oncology and liquid biopsies to fuel market 219 7.3.5 OTHER MEDICAL APPLICATIONS 222 7.4 OTHER INDUSTRIAL APPLICATIONS 225 8 CELL COUNTING MARKET, BY END USER 228 8.1 INTRODUCTION 229 8.2 ACADEMIC & RESEARCH INSTITUTES 229 8.2.1 ADVANCEMENTS IN STEM CELL RESEARCH AND GROWING FOCUS ON LIFE SCIENCES TO PROPEL MARKET 229 8.3 HOSPITALS & DIAGNOSTIC LABORATORIES 233 8.3.1 RISING PREVALENCE OF CHRONIC & INFECTIOUS DISEASES TO DRIVE MARKET 233 8.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 236 8.4.1 EXPANDING PIPELINE OF BIOLOGICS TO FUEL MARKET 236 8.5 OTHER END USERS 239 9 CELL COUNTING MARKET, BY REGION 242 9.1 INTRODUCTION 243 9.2 NORTH AMERICA 243 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 244 9.2.2 US 250 9.2.2.1 US to dominate North American cell counting market during study period 250 9.2.3 CANADA 255 9.2.3.1 Rising demand for advanced research tools in biopharmaceutical and academic research to drive market 255 9.3 EUROPE 260 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 260 9.3.2 GERMANY 266 9.3.2.1 Robust biopharma manufacturing and substantial federal R&D investments to aid market growth 266 9.3.3 UK 271 9.3.3.1 Favorable government funding for pharmaceutical & biotechnology research to support market growth 271 9.3.4 FRANCE 276 9.3.4.1 Favorable government initiatives and increased investments by foreign pharmaceutical companies to aid market growth 276 9.3.5 ITALY 281 9.3.5.1 Advanced life science research biomanufacturing facilities to augment market growth 281 9.3.6 SPAIN 286 9.3.6.1 Emphasis on biopharmaceutical innovation and cancer research to stimulate market growth 286 9.3.7 REST OF EUROPE 291 9.4 ASIA PACIFIC 296 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 296 9.4.2 CHINA 303 9.4.2.1 Growing prominence in clinical trials and biologics production to fuel market growth 303 9.4.3 JAPAN 308 9.4.3.1 High availability of funding and technological expertise to support market growth 308 9.4.4 INDIA 313 9.4.4.1 Favorable FDI regulations in pharmaceutical industry to boost market growth 313 9.4.5 SOUTH KOREA 318 9.4.5.1 Increasing healthcare expenditure and rising government R&D budget to fuel uptake 318 9.4.6 AUSTRALIA 323 9.4.6.1 Focus on translational research and clinical trials in cancer therapies and regenerative medicines to drive market 323 9.4.7 REST OF ASIA PACIFIC 328 9.5 LATIN AMERICA 333 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 334 9.5.2 BRAZIL 339 9.5.2.1 Robust healthcare infrastructure and high prevalence of chronic diseases to propel demand for cell-counting technologies 339 9.5.3 MEXICO 343 9.5.3.1 Burgeoning pharmaceutical industry and increased collaborations among industry leaders to propel market growth 343 9.5.4 REST OF LATIN AMERICA 348 9.6 MIDDLE EAST 353 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST 353 9.6.2 GCC COUNTRIES 359 9.6.2.1 Saudi Arabia 364 9.6.2.1.1 Growing focus on public-private partnerships and rising investments in healthcare modernization to drive market 364 9.6.2.2 UAE 370 9.6.2.2.1 World-class healthcare infrastructure to drive adoption of cell counting technologies 370 9.6.2.3 Rest of GCC Countries 375 9.6.3 REST OF MIDDLE EAST 380 9.7 AFRICA 386 9.7.1 HIGH GOVERNMENT HEALTHCARE BUDGET AND INCREASED POPULARITY AS BIOTECH HUB TO SUPPORT MARKET GROWTH 386 9.7.2 MACROECONOMIC OUTLOOK FOR AFRICA 386 10 COMPETITIVE LANDSCAPE 392 10.1 OVERVIEW 392 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2021–2025 392 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CELL COUNTING MARKET 393 10.3 REVENUE ANALYSIS, 2019–2023 394 10.4 MARKET SHARE ANALYSIS, 2023 395 10.5 COMPANY VALUATION AND FINANCIAL METRICS 397 10.5.1 COMPANY VALUATION 397 10.5.2 FINANCIAL METRICS 398 10.6 BRAND/PRODUCT COMPARISON 399 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 400 10.7.1 STARS 400 10.7.2 EMERGING LEADERS 400 10.7.3 PERVASIVE PLAYERS 400 10.7.4 PARTICIPANTS 400   10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 402 10.7.5.1 Company footprint 402 10.7.5.2 Region footprint 403 10.7.5.3 Product footprint 404 10.7.5.4 Application footprint 405 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 406 10.8.1 PROGRESSIVE COMPANIES 406 10.8.2 RESPONSIVE COMPANIES 406 10.8.3 DYNAMIC COMPANIES 406 10.8.4 STARTING BLOCKS 406 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 408 10.8.5.1 Detailed list of key startups/SMEs 408 10.8.5.2 Competitive benchmarking of startups/SMEs 409 10.9 COMPETITIVE SCENARIO 410 10.9.1 PRODUCT LAUNCHES 410 10.9.2 DEALS 411 10.9.3 EXPANSIONS 412 11 COMPANY PROFILES 413 11.1 KEY PLAYERS 413 11.1.1 DANAHER CORPORATION 413 11.1.1.1 Business overview 413 11.1.1.2 Products offered 415 11.1.1.3 Recent developments 419 11.1.1.3.1 Product launches 419 11.1.1.3.2 Deals 419 11.1.1.4 MnM view 419 11.1.1.4.1 Key strengths 419 11.1.1.4.2 Strategic choices 420 11.1.1.4.3 Weaknesses and competitive threats 420 11.1.2 THERMO FISHER SCIENTIFIC INC. 421 11.1.2.1 Business overview 421 11.1.2.2 Products offered 423 11.1.2.3 Recent developments 425 11.1.2.3.1 Deals 425 11.1.2.4 MnM view 425 11.1.2.4.1 Key strengths 425 11.1.2.4.2 Strategic choices 426 11.1.2.4.3 Weaknesses and competitive threats 426   11.1.3 AGILENT TECHNOLOGIES, INC. 427 11.1.3.1 Business overview 427 11.1.3.2 Products offered 429 11.1.3.3 Recent developments 433 11.1.3.3.1 Expansions 433 11.1.3.4 MnM view 434 11.1.3.4.1 Key strengths 434 11.1.3.4.2 Strategic choices 434 11.1.3.4.3 Weaknesses and competitive threats 434 11.1.4 BD 435 11.1.4.1 Business overview 435 11.1.4.2 Products offered 437 11.1.4.3 Recent developments 440 11.1.4.3.1 Product launches 440 11.1.4.4 MnM view 441 11.1.4.4.1 Key strengths 441 11.1.4.4.2 Strategic choices 441 11.1.4.4.3 Weaknesses and competitive threats 441 11.1.5 ABBOTT LABORATORIES 442 11.1.5.1 Business overview 442 11.1.5.2 Products offered 444 11.1.5.3 MnM view 444 11.1.5.3.1 Key strengths 444 11.1.5.3.2 Strategic choices 444 11.1.5.3.3 Weaknesses and competitive threats 445 11.1.6 MERCK KGAA 446 11.1.6.1 Business overview 446 11.1.6.2 Products offered 448 11.1.6.3 Recent developments 450 11.1.6.3.1 Deals 450 11.1.6.3.2 Expansions 450 11.1.7 REVVITY 451 11.1.7.1 Business overview 451 11.1.7.2 Products offered 453 11.1.7.3 Recent developments 456 11.1.7.3.1 Product launches 456 11.1.7.3.2 Deals 456 11.1.8 BIO-RAD LABORATORIES, INC. 457 11.1.8.1 Business overview 457 11.1.8.2 Products offered 459   11.1.9 CORNING INCORPORATED 463 11.1.9.1 Business overview 463 11.1.9.2 Products offered 465 11.1.10 TECAN TRADING AG 467 11.1.10.1 Business overview 467 11.1.10.2 Products offered 469 11.1.11 BOULE 470 11.1.11.1 Business overview 470 11.1.11.2 Products offered 472 11.1.11.3 Recent developments 473 11.1.11.3.1 Deals 473 11.1.12 HORIBA 474 11.1.12.1 Business overview 474 11.1.12.2 Products offered 476 11.1.12.3 Recent developments 477 11.1.12.3.1 Product launches 477 11.1.13 SIEMENS HEALTHINEERS AG 478 11.1.13.1 Business overview 478 11.1.13.2 Products offered 480 11.1.13.3 Recent developments 481 11.1.13.3.1 Product launches 481 11.1.14 EVIDENT 482 11.1.14.1 Business overview 482 11.1.14.2 Products offered 482 11.1.14.3 Recent developments 484 11.1.14.3.1 Product launches 484 11.1.14.3.2 Deals 484 11.1.14.3.3 Expansions 484 11.1.15 F. HOFFMANN-LA ROCHE LTD 485 11.1.15.1 Business overview 485 11.1.15.2 Products offered 487 11.1.16 SYSMEX CORPORATION 488 11.1.16.1 Business overview 488 11.1.16.2 Products offered 489 11.1.16.3 Recent developments 491 11.1.16.3.1 Product launches 491 11.1.16.3.2 Deals 492 11.2 OTHER PLAYERS 493 11.2.1 CYTEK BIOSCIENCES 493 11.2.2 TIP BIOSYSTEMS 494 11.2.3 ALIGNED GENETICS 495 11.2.4 YOKOGAWA ELECTRIC CORPORATION 496 11.2.5 COLE-PARMER INSTRUMENT COMPANY, LLC 497 11.2.6 MILTENYI BIOTEC 498 11.2.7 LONZA 499 11.2.8 BIOLINE TECHNOLOGIES 500 11.2.9 NIKON CORPORATION 501 11.2.10 AXON BIOSYTEMS, INC. 502 11.2.11 CREATIVE BIOARRAY 503 12 APPENDIX 504 12.1 DISCUSSION GUIDE 504 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 508 12.3 CUSTOMIZATION OPTIONS 510 12.4 RELATED REPORTS 510 12.5 AUTHOR DETAILS 511
圖表清單 List of Tables & Figures
TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 59 TABLE 2 CELL COUNTING MARKET: RISK ANALYSIS 62 TABLE 3 CELL COUNTING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 70 TABLE 4 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 75 TABLE 5 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY REGION, 2022–2024 77 TABLE 6 CELL COUNTING MARKET: RAW MATERIAL PROVIDERS 82 TABLE 7 CELL COUNTING MARKET: PRODUCT MANUFACTURERS/PROVIDERS 83 TABLE 8 CELL COUNTING MARKET: END USERS 83 TABLE 9 CELL COUNTING MARKET: REGULATORY BODIES 84 TABLE 10 INNOVATIONS AND PATENT REGISTRATIONS, 2023–2024 89 TABLE 11 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017–2021 (USD THOUSAND) 90 TABLE 12 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (USD THOUSAND) 91 TABLE 13 IMPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (UNITS) 91 TABLE 14 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902780), BY COUNTRY, 2017–2021 (USD THOUSAND) 92 TABLE 15 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (USD THOUSAND) 92 TABLE 16 EXPORT DATA FOR FLOW CYTOMETERS (HS CODE 902789), BY COUNTRY, 2022–2023 (UNITS) 93 TABLE 17 CELL COUNTING MARKET: KEY CONFERENCES & EVENTS, 2025–2026 93 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 95 TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 22 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96 TABLE 23 CELL COUNTING MARKET: PORTER’S FIVE FORCES ANALYSIS 97 TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 100 TABLE 25 KEY BUYING CRITERIA FOR CELL COUNTING PRODUCTS, BY END USER 101 TABLE 26 CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 106 TABLE 27 CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 107 TABLE 28 CELL COUNTING CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 107 TABLE 29 NORTH AMERICA: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 107 TABLE 30 EUROPE: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 108 TABLE 31 ASIA PACIFIC: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 108 TABLE 32 LATIN AMERICA: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109 TABLE 33 MIDDLE EAST: CELL COUNTING CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 109 TABLE 34 GCC COUNTRIES: CELL COUNTING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 109 TABLE 35 CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 110 TABLE 36 NORTH AMERICA: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 37 EUROPE: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 38 ASIA PACIFIC: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 111 TABLE 39 LATIN AMERICA: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 112 TABLE 40 MIDDLE EAST: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 112 TABLE 41 GCC COUNTRIES: CELL COUNTING MEDIA, SERA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 112 TABLE 42 CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 113 TABLE 43 CELL COUNTING ASSAY KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 114 TABLE 44 NORTH AMERICA: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114 TABLE 45 EUROPE: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 114 TABLE 46 ASIA PACIFIC: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115 TABLE 47 LATIN AMERICA: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 115 TABLE 48 MIDDLE EAST: CELL COUNTING ASSAY KITS MARKET, BY REGION, 2022–2029 (USD MILLION) 115 TABLE 49 GCC COUNTRIES: CELL COUNTING ASSAY KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 116 TABLE 50 CELL VIABILITY ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 117 TABLE 51 NORTH AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117 TABLE 52 EUROPE: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 117 TABLE 53 ASIA PACIFIC: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118 TABLE 54 LATIN AMERICA: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 118 TABLE 55 MIDDLE EAST: CELL VIABILITY ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 118 TABLE 56 GCC COUNTRIES: CELL VIABILITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 119 TABLE 57 CELL STAINING ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 120 TABLE 58 NORTH AMERICA: CELL STAINING ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120 TABLE 59 EUROPE: CELL STAINING ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 120 TABLE 60 ASIA PACIFIC: CELL STAINING ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121 TABLE 61 LATIN AMERICA: CELL STAINING ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 121 TABLE 62 MIDDLE EAST: CELL STAINING ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 121 TABLE 63 GCC COUNTRIES: CELL STAINING ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 122 TABLE 64 CYTOTOXICITY ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 123 TABLE 65 NORTH AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123 TABLE 66 EUROPE: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 123 TABLE 67 ASIA PACIFIC: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124 TABLE 68 LATIN AMERICA: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 124 TABLE 69 MIDDLE EAST: CYTOTOXICITY ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 124 TABLE 70 GCC COUNTRIES: CYTOTOXICITY ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 125 TABLE 71 CALORIMETRIC ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 126 TABLE 72 NORTH AMERICA: CALORIMETRIC ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 73 EUROPE: CALORIMETRIC ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 126 TABLE 74 ASIA PACIFIC: CALORIMETRIC ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127 TABLE 75 LATIN AMERICA: CALORIMETRIC ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 127 TABLE 76 MIDDLE EAST: CALORIMETRIC ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 127 TABLE 77 GCC COUNTRIES: CALORIMETRIC ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 128 TABLE 78 OTHER ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 129 TABLE 79 NORTH AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129 TABLE 80 EUROPE: OTHER ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 129 TABLE 81 ASIA PACIFIC: OTHER ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130 TABLE 82 LATIN AMERICA: OTHER ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 130 TABLE 83 MIDDLE EAST: OTHER ASSAYS MARKET, BY REGION, 2022–2029 (USD MILLION) 130 TABLE 84 GCC COUNTRIES: OTHER ASSAYS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 131 TABLE 85 CELL COUNTING MICROPLATES MARKET, BY REGION, 2022–2029 (USD MILLION) 132 TABLE 86 NORTH AMERICA: CELL COUNTING MICROPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132 TABLE 87 EUROPE: CELL COUNTING MICROPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132 TABLE 88 ASIA PACIFIC: CELL COUNTING MICROPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133 TABLE 89 LATIN AMERICA: CELL COUNTING MICROPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133 TABLE 90 MIDDLE EAST: CELL COUNTING MICROPLATES MARKET, BY REGION, 2022–2029 (USD MILLION) 133 TABLE 91 GCC COUNTRIES: CELL COUNTING MICROPLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134 TABLE 92 CELL COUNTING ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 134 TABLE 93 NORTH AMERICA: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135 TABLE 94 EUROPE: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135 TABLE 95 ASIA PACIFIC: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 135 TABLE 96 LATIN AMERICA: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136 TABLE 97 MIDDLE EAST: CELL COUNTING ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 136 TABLE 98 GCC COUNTRIES: CELL COUNTING ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136 TABLE 99 OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 137 TABLE 100 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137 TABLE 101 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138 TABLE 102 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138 TABLE 103 LATIN AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138 TABLE 104 MIDDLE EAST: OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION) 139 TABLE 105 GCC COUNTRIES: OTHER CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139 TABLE 106 CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 140 TABLE 107 CELL COUNTING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 140 TABLE 108 NORTH AMERICA: CELL COUNTING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 140 TABLE 109 EUROPE: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141 TABLE 110 ASIA PACIFIC: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141 TABLE 111 LATIN AMERICA: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141 TABLE 112 MIDDLE EAST: CELL COUNTING INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 142 TABLE 113 GCC COUNTRIES: CELL COUNTING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142 TABLE 114 CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 143 TABLE 115 CELL COUNTING SPECTROPHOTOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 143 TABLE 116 NORTH AMERICA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143 TABLE 117 EUROPE: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144 TABLE 118 ASIA PACIFIC: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144 TABLE 119 LATIN AMERICA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144 TABLE 120 MIDDLE EAST: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 145 TABLE 121 GCC COUNTRIES: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145 TABLE 122 SINGLE-MODE READERS MARKET, BY REGION, 2022–2029 (USD MILLION) 146 TABLE 123 NORTH AMERICA: SINGLE-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146 TABLE 124 EUROPE: SINGLE-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146 TABLE 125 ASIA PACIFIC: SINGLE-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147 TABLE 126 LATIN AMERICA: SINGLE-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147 TABLE 127 MIDDLE EAST: SINGLE-MODE READERS MARKET, BY REGION, 2022–2029 (USD MILLION) 147 TABLE 128 GCC COUNTRIES: SINGLE-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 148 TABLE 129 MULTI-MODE READERS MARKET, BY REGION, 2022–2029 (USD MILLION) 148 TABLE 130 NORTH AMERICA: MULTI-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 131 EUROPE: MULTI-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 132 ASIA PACIFIC: MULTI-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149 TABLE 133 LATIN AMERICA: MULTI-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150 TABLE 134 MIDDLE EAST: MULTI-MODE READERS MARKET, BY REGION, 2022–2029 (USD MILLION) 150 TABLE 135 GCC COUNTRIES: MULTI-MODE READERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150 TABLE 136 CELL COUNTING FLOW CYTOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 151 TABLE 137 NORTH AMERICA: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151 TABLE 138 EUROPE: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152 TABLE 139 ASIA PACIFIC: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152 TABLE 140 LATIN AMERICA: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152 TABLE 141 MIDDLE EAST: CELL COUNTING FLOW CYTOMETERS MARKET, BY REGION, 2022–2029 (USD MILLION) 153 TABLE 142 GCC COUNTRIES: CELL COUNTING FLOW CYTOMETERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153 TABLE 143 CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 154 TABLE 144 CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 154 TABLE 145 NORTH AMERICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154 TABLE 146 EUROPE: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155 TABLE 147 ASIA PACIFIC: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155 TABLE 148 LATIN AMERICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 155 TABLE 149 MIDDLE EAST: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 156 TABLE 150 GCC COUNTRIES: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156 TABLE 151 FULLY AUTOMATED ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 157 TABLE 152 NORTH AMERICA: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157 TABLE 153 EUROPE: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158 TABLE 154 ASIA PACIFIC: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158 TABLE 155 LATIN AMERICA: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158 TABLE 156 MIDDLE EAST: FULLY AUTOMATED ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 159 TABLE 157 GCC COUNTRIES: FULLY AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 159 TABLE 158 SEMI-AUTOMATED ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 160 TABLE 159 NORTH AMERICA: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160 TABLE 160 EUROPE: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160 TABLE 161 ASIA PACIFIC: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161 TABLE 162 LATIN AMERICA: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161 TABLE 163 MIDDLE EAST: SEMI-AUTOMATED ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION) 161 TABLE 164 GCC COUNTRIES: SEMI-AUTOMATED ANALYZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162 TABLE 165 CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 162 TABLE 166 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163 TABLE 167 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163 TABLE 168 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 163 TABLE 169 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164 TABLE 170 MIDDLE EAST: CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 164 TABLE 171 GCC COUNTRIES: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164 TABLE 172 CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 165 TABLE 173 AUTOMATED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 165 TABLE 174 NORTH AMERICA: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 166 TABLE 175 EUROPE: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 166 TABLE 176 ASIA PACIFIC: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 166 TABLE 177 LATIN AMERICA: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167 TABLE 178 MIDDLE EAST: AUTOMATED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 167 TABLE 179 GCC COUNTRIES: AUTOMATED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167 TABLE 180 MANUAL CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 168 TABLE 181 NORTH AMERICA: MANUAL CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168 TABLE 182 EUROPE: MANUAL CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169 TABLE 183 ASIA PACIFIC: MANUAL CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169 TABLE 184 LATIN AMERICA: MANUAL CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169 TABLE 185 MIDDLE EAST: MANUAL CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 170 TABLE 186 GCC COUNTRIES: MANUAL CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 170 TABLE 187 CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 171 TABLE 188 FLUORESCENCE-BASED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 172 TABLE 189 NORTH AMERICA: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 172 TABLE 190 EUROPE: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 172 TABLE 191 ASIA PACIFIC: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173 TABLE 192 LATIN AMERICA: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173 TABLE 193 MIDDLE EAST: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 173 TABLE 194 GCC COUNTRIES: FLUORESCENCE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174 TABLE 195 IMAGE-BASED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 174 TABLE 196 NORTH AMERICA: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175 TABLE 197 EUROPE: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175 TABLE 198 ASIA PACIFIC: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175 TABLE 199 LATIN AMERICA: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176 TABLE 200 MIDDLE EAST: IMAGE-BASED CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 176 TABLE 201 GCC COUNTRIES: IMAGE-BASED CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176 TABLE 202 BRIGHTFIELD CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 177 TABLE 203 NORTH AMERICA: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177 TABLE 204 EUROPE: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178 TABLE 205 ASIA PACIFIC: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178 TABLE 206 LATIN AMERICA: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178 TABLE 207 MIDDLE EAST: BRIGHTFIELD CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 179 TABLE 208 GCC COUNTRIES: BRIGHTFIELD CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 179 TABLE 209 OTHER CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 180 TABLE 210 NORTH AMERICA: OTHER CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180 TABLE 211 EUROPE: OTHER CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 180 TABLE 212 ASIA PACIFIC: OTHER CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181 TABLE 213 LATIN AMERICA: OTHER CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181 TABLE 214 MIDDLE EAST: OTHER CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 181 TABLE 215 GCC COUNTRIES: OTHER CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182 TABLE 216 CELL COUNTING MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION) 182 TABLE 217 NORTH AMERICA: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183 TABLE 218 EUROPE: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183 TABLE 219 ASIA PACIFIC: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183 TABLE 220 LATIN AMERICA: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184 TABLE 221 MIDDLE EAST: CELL COUNTING MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION) 184 TABLE 222 GCC COUNTRIES: CELL COUNTING MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 184 TABLE 223 OTHER INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 185 TABLE 224 NORTH AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185 TABLE 225 EUROPE: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186 TABLE 226 ASIA PACIFIC: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186 TABLE 227 LATIN AMERICA: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186 TABLE 228 MIDDLE EAST: OTHER INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION) 187 TABLE 229 GCC COUNTRIES: OTHER INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187 TABLE 230 CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 189 TABLE 231 CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 190 TABLE 232 CELL COUNTING RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 190 TABLE 233 NORTH AMERICA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191 TABLE 234 EUROPE: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 191 TABLE 235 ASIA PACIFIC: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 192 TABLE 236 LATIN AMERICA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 192 TABLE 237 MIDDLE EAST: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 192 TABLE 238 GCC COUNTRIES: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 193 TABLE 239 CANCER RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 194 TABLE 240 NORTH AMERICA: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 194 TABLE 241 EUROPE: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195 TABLE 242 ASIA PACIFIC: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 195 TABLE 243 LATIN AMERICA: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 196 TABLE 244 MIDDLE EAST: CANCER RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 196 TABLE 245 GCC COUNTRIES: CANCER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 196 TABLE 246 IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 197 TABLE 247 NORTH AMERICA: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 197 TABLE 248 EUROPE: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198 TABLE 249 ASIA PACIFIC: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198 TABLE 250 LATIN AMERICA: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 198 TABLE 251 MIDDLE EAST: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 199 TABLE 252 GCC COUNTRIES: IMMUNOLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 199 TABLE 253 NEUROLOGY RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 200 TABLE 254 NORTH AMERICA: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 200 TABLE 255 EUROPE: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 200 TABLE 256 ASIA PACIFIC: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201 TABLE 257 LATIN AMERICA: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201 TABLE 258 MIDDLE EAST: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 201 TABLE 259 GCC COUNTRIES: NEUROLOGY RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202 TABLE 260 STEM CELL RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 203 TABLE 261 NORTH AMERICA: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 203 TABLE 262 EUROPE: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 203 TABLE 263 ASIA PACIFIC: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204 TABLE 264 LATIN AMERICA: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204 TABLE 265 MIDDLE EAST: STEM CELL RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 204 TABLE 266 GCC COUNTRIES: STEM CELL RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205 TABLE 267 OTHER RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 205 TABLE 268 NORTH AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206 TABLE 269 EUROPE: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206 TABLE 270 ASIA PACIFIC: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206 TABLE 271 LATIN AMERICA: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207 TABLE 272 MIDDLE EAST: OTHER RESEARCH APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 207 TABLE 273 GCC COUNTRIES: OTHER RESEARCH APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207 TABLE 274 CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 208 TABLE 275 CELL COUNTING MEDICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 209 TABLE 276 NORTH AMERICA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209 TABLE 277 EUROPE: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209 TABLE 278 ASIA PACIFIC: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210 TABLE 279 LATIN AMERICA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210 TABLE 280 MIDDLE EAST: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 210 TABLE 281 GCC COUNTRIES: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211 TABLE 282 HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY REGION, 2022–2029 (USD MILLION) 212 TABLE 283 NORTH AMERICA: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212 TABLE 284 EUROPE: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212 TABLE 285 ASIA PACIFIC: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213 TABLE 286 LATIN AMERICA: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 213 TABLE 287 MIDDLE EAST: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY REGION, 2022–2029 (USD MILLION) 213 TABLE 288 GCC COUNTRIES: HEMATOLOGY & COMPLETE BLOOD COUNT MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214 TABLE 289 NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 214 TABLE 290 NORTH AMERICA: NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215 TABLE 291 EUROPE: NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215 TABLE 292 ASIA PACIFIC: NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215 TABLE 293 LATIN AMERICA: NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216 TABLE 294 MIDDLE EAST: NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, BY REGION, 2022–2029 (USD MILLION) 216 TABLE 295 GCC COUNTRIES: NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216 TABLE 296 IN VITRO FERTILIZATION MARKET, BY REGION, 2022–2029 (USD MILLION) 217 TABLE 297 NORTH AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 217 TABLE 298 EUROPE: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218 TABLE 299 ASIA PACIFIC: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218 TABLE 300 LATIN AMERICA: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 218 TABLE 301 MIDDLE EAST: IN VITRO FERTILIZATION MARKET, BY REGION, 2022–2029 (USD MILLION) 219 TABLE 302 GCC COUNTRIES: IN VITRO FERTILIZATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 219 TABLE 303 CIRCULATING TUMOR CELL DETECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 220 TABLE 304 NORTH AMERICA: CIRCULATING TUMOR CELL DETECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 220 TABLE 305 EUROPE: CIRCULATING TUMOR CELL DETECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 220 TABLE 306 ASIA PACIFIC: CIRCULATING TUMOR CELL DETECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 221 TABLE 307 LATIN AMERICA: CIRCULATING TUMOR CELL DETECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 221 TABLE 308 MIDDLE EAST: CIRCULATING TUMOR CELL DETECTION MARKET, BY REGION, 2022–2029 (USD MILLION) 221 TABLE 309 GCC COUNTRIES: CIRCULATING TUMOR CELL DETECTION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 222 TABLE 310 OTHER MEDICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 222 TABLE 311 NORTH AMERICA: OTHER MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 223 TABLE 312 EUROPE: OTHER MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 223 TABLE 313 ASIA PACIFIC: OTHER MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 223 TABLE 314 LATIN AMERICA: OTHER MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 224 TABLE 315 MIDDLE EAST: OTHER MEDICAL APPLICATIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 224 TABLE 316 GCC COUNTRIES: OTHER MEDICAL APPLICATIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 224 TABLE 317 CELL COUNTING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 225 TABLE 318 NORTH AMERICA: CELL COUNTING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 226 TABLE 319 EUROPE: CELL COUNTING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 226 TABLE 320 ASIA PACIFIC: CELL COUNTING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 226 TABLE 321 LATIN AMERICA: CELL COUNTING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 227 TABLE 322 MIDDLE EAST: CELL COUNTING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 227 TABLE 323 GCC COUNTRIES: CELL COUNTING MARKET FOR OTHER INDUSTRIAL APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 227 TABLE 324 CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 229 TABLE 325 CELL COUNTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 230 TABLE 326 NORTH AMERICA: CELL COUNTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 230 TABLE 327 EUROPE: CELL COUNTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 231 TABLE 328 ASIA PACIFIC: CELL COUNTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 231 TABLE 329 LATIN AMERICA: CELL COUNTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 232 TABLE 330 MIDDLE EAST: CELL COUNTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 232 TABLE 331 GCC COUNTRIES: CELL COUNTING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 232 TABLE 332 CELL COUNTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 233 TABLE 333 NORTH AMERICA: CELL COUNTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 234 TABLE 334 EUROPE: CELL COUNTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 234 TABLE 335 ASIA PACIFIC: CELL COUNTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 234 TABLE 336 LATIN AMERICA: CELL COUNTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 235 TABLE 337 MIDDLE EAST: CELL COUNTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION) 235 TABLE 338 GCC COUNTRIES: CELL COUNTING MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION) 235 TABLE 339 CELL COUNTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 237 TABLE 340 NORTH AMERICA: CELL COUNTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 237 TABLE 341 EUROPE: CELL COUNTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 237 TABLE 342 ASIA PACIFIC: CELL COUNTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 238 TABLE 343 LATIN AMERICA: CELL COUNTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 238 TABLE 344 MIDDLE EAST: CELL COUNTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 238 TABLE 345 GCC COUNTRIES: CELL COUNTING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 239 TABLE 346 CELL COUNTING MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 239 TABLE 347 NORTH AMERICA: CELL COUNTING MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 240 TABLE 348 EUROPE: CELL COUNTING MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 240 TABLE 349 ASIA PACIFIC: CELL COUNTING MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 240 TABLE 350 LATIN AMERICA: CELL COUNTING MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 241 TABLE 351 MIDDLE EAST: CELL COUNTING MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 241 TABLE 352 GCC COUNTRIES: CELL COUNTING MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 241 TABLE 353 CELL COUNTING MARKET, BY REGION, 2022–2029 (USD MILLION) 243 TABLE 354 NORTH AMERICA: KEY MACROINDICATORS 244 TABLE 355 NORTH AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 245 TABLE 356 NORTH AMERICA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 246 TABLE 357 NORTH AMERICA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 246 TABLE 358 NORTH AMERICA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 246 TABLE 359 NORTH AMERICA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 247 TABLE 360 NORTH AMERICA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 247 TABLE 361 NORTH AMERICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 247 TABLE 362 NORTH AMERICA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 248 TABLE 363 NORTH AMERICA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 248 TABLE 364 NORTH AMERICA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 248 TABLE 365 NORTH AMERICA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 249 TABLE 366 NORTH AMERICA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 249 TABLE 367 NORTH AMERICA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 250 TABLE 368 US: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 251 TABLE 369 US: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 251 TABLE 370 US: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 252 TABLE 371 US: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 252 TABLE 372 US: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 252 TABLE 373 US: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 253 TABLE 374 US: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 253 TABLE 375 US: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 253 TABLE 376 US: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 254 TABLE 377 US: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 254 TABLE 378 US: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 254 TABLE 379 US: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 255 TABLE 380 CANADA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 256 TABLE 381 CANADA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 256 TABLE 382 CANADA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 256 TABLE 383 CANADA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 257 TABLE 384 CANADA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 257 TABLE 385 CANADA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 257 TABLE 386 CANADA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 258 TABLE 387 CANADA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 258 TABLE 388 CANADA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 258 TABLE 389 CANADA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 259 TABLE 390 CANADA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 259 TABLE 391 CANADA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 260 TABLE 392 EUROPE: KEY MACROINDICATORS 261 TABLE 393 EUROPE: CELL COUNTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 261 TABLE 394 EUROPE: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 262 TABLE 395 EUROPE: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 262 TABLE 396 EUROPE: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 262 TABLE 397 EUROPE: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 263 TABLE 398 EUROPE: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 263 TABLE 399 EUROPE: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 263 TABLE 400 EUROPE: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 264 TABLE 401 EUROPE: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 264 TABLE 402 EUROPE: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 264 TABLE 403 EUROPE: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 265 TABLE 404 EUROPE: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 265 TABLE 405 EUROPE: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 266 TABLE 406 GERMANY: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 267 TABLE 407 GERMANY: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 267 TABLE 408 GERMANY: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 267 TABLE 409 GERMANY: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 268 TABLE 410 GERMANY: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 268 TABLE 411 GERMANY: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 268 TABLE 412 GERMANY: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 269 TABLE 413 GERMANY: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 269 TABLE 414 GERMANY: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 269 TABLE 415 GERMANY: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 270 TABLE 416 GERMANY: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 270 TABLE 417 GERMANY: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 271 TABLE 418 UK: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 272 TABLE 419 UK: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 272 TABLE 420 UK: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 272 TABLE 421 UK: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 273 TABLE 422 UK: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 273 TABLE 423 UK: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 273 TABLE 424 UK: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 274 TABLE 425 UK: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 274 TABLE 426 UK: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 274 TABLE 427 UK: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 275 TABLE 428 UK: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 275 TABLE 429 UK: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 276 TABLE 430 FRANCE: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 277 TABLE 431 FRANCE: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 277 TABLE 432 FRANCE: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 277 TABLE 433 FRANCE: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 278 TABLE 434 FRANCE: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 278 TABLE 435 FRANCE: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 278 TABLE 436 FRANCE: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 279 TABLE 437 FRANCE: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 279 TABLE 438 FRANCE: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 279 TABLE 439 FRANCE: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 280 TABLE 440 FRANCE: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 280 TABLE 441 FRANCE: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 281 TABLE 442 ITALY: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 282 TABLE 443 ITALY: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 282 TABLE 444 ITALY: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 282 TABLE 445 ITALY: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 283 TABLE 446 ITALY: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 283 TABLE 447 ITALY: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 283 TABLE 448 ITALY: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 284 TABLE 449 ITALY: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 284 TABLE 450 ITALY: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 284 TABLE 451 ITALY: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 285 TABLE 452 ITALY: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 285 TABLE 453 ITALY: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 286 TABLE 454 SPAIN: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 287 TABLE 455 SPAIN: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 287 TABLE 456 SPAIN: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 287 TABLE 457 SPAIN: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 288 TABLE 458 SPAIN: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 288 TABLE 459 SPAIN: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 288 TABLE 460 SPAIN: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 289 TABLE 461 SPAIN: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 289 TABLE 462 SPAIN: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 289 TABLE 463 SPAIN: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 290 TABLE 464 SPAIN: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 290 TABLE 465 SPAIN: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 291 TABLE 466 REST OF EUROPE: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 292 TABLE 467 REST OF EUROPE: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 292 TABLE 468 REST OF EUROPE: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 292 TABLE 469 REST OF EUROPE: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 293 TABLE 470 REST OF EUROPE: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 293 TABLE 471 REST OF EUROPE: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 293 TABLE 472 REST OF EUROPE: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 294 TABLE 473 REST OF EUROPE: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 294 TABLE 474 REST OF EUROPE: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 294 TABLE 475 REST OF EUROPE: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 295 TABLE 476 REST OF EUROPE: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 295 TABLE 477 REST OF EUROPE: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 296 TABLE 478 ASIA PACIFIC: KEY MACROINDICATORS 297 TABLE 479 ASIA PACIFIC: CELL COUNTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 299 TABLE 480 ASIA PACIFIC: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 299 TABLE 481 ASIA PACIFIC: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 299 TABLE 482 ASIA PACIFIC: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 300 TABLE 483 ASIA PACIFIC: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 300 TABLE 484 ASIA PACIFIC: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 301 TABLE 485 ASIA PACIFIC: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 301 TABLE 486 ASIA PACIFIC: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 301 TABLE 487 ASIA PACIFIC: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 302 TABLE 488 ASIA PACIFIC: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 302 TABLE 489 ASIA PACIFIC: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 302 TABLE 490 ASIA PACIFIC: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 303 TABLE 491 ASIA PACIFIC: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 303 TABLE 492 CHINA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 304 TABLE 493 CHINA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 304 TABLE 494 CHINA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 305 TABLE 495 CHINA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 305 TABLE 496 CHINA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 305 TABLE 497 CHINA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 306 TABLE 498 CHINA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 306 TABLE 499 CHINA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 306 TABLE 500 CHINA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 307 TABLE 501 CHINA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 307 TABLE 502 CHINA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 307 TABLE 503 CHINA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 308 TABLE 504 JAPAN: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 309 TABLE 505 JAPAN: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 309 TABLE 506 JAPAN: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 309 TABLE 507 JAPAN: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 310 TABLE 508 JAPAN: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 310 TABLE 509 JAPAN: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 310 TABLE 510 JAPAN: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 311 TABLE 511 JAPAN: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 311 TABLE 512 JAPAN: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 311 TABLE 513 JAPAN: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 312 TABLE 514 JAPAN: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 312 TABLE 515 JAPAN: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 313 TABLE 516 INDIA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 314 TABLE 517 INDIA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 314 TABLE 518 INDIA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 314 TABLE 519 INDIA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 315 TABLE 520 INDIA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 315 TABLE 521 INDIA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 315 TABLE 522 INDIA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 316 TABLE 523 INDIA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 316 TABLE 524 INDIA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 316 TABLE 525 INDIA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 317 TABLE 526 INDIA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 317 TABLE 527 INDIA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 318 TABLE 528 SOUTH KOREA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 318 TABLE 529 SOUTH KOREA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 319 TABLE 530 SOUTH KOREA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 319 TABLE 531 SOUTH KOREA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 320 TABLE 532 SOUTH KOREA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 320 TABLE 533 SOUTH KOREA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 320 TABLE 534 SOUTH KOREA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 321 TABLE 535 SOUTH KOREA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 321 TABLE 536 SOUTH KOREA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 321 TABLE 537 SOUTH KOREA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 322 TABLE 538 SOUTH KOREA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 322 TABLE 539 SOUTH KOREA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 323 TABLE 540 AUSTRALIA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 324 TABLE 541 AUSTRALIA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 324 TABLE 542 AUSTRALIA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 324 TABLE 543 AUSTRALIA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 325 TABLE 544 AUSTRALIA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 325 TABLE 545 AUSTRALIA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 325 TABLE 546 AUSTRALIA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 326 TABLE 547 AUSTRALIA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 326 TABLE 548 AUSTRALIA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 326 TABLE 549 AUSTRALIA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 327 TABLE 550 AUSTRALIA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 327 TABLE 551 AUSTRALIA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 328 TABLE 552 REST OF ASIA PACIFIC: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 329 TABLE 553 REST OF ASIA PACIFIC: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 329 TABLE 554 REST OF ASIA PACIFIC: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 329 TABLE 555 REST OF ASIA PACIFIC: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 330 TABLE 556 REST OF ASIA PACIFIC: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 330 TABLE 557 REST OF ASIA PACIFIC: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 330 TABLE 558 REST OF ASIA PACIFIC: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 331 TABLE 559 REST OF ASIA PACIFIC: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 331 TABLE 560 REST OF ASIA PACIFIC: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 331 TABLE 561 REST OF ASIA PACIFIC: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 332 TABLE 562 REST OF ASIA PACIFIC: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 332 TABLE 563 REST OF ASIA PACIFIC: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 333 TABLE 564 LATIN AMERICA: KEY MACROINDICATORS 334 TABLE 565 LATIN AMERICA: CELL COUNTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 334 TABLE 566 LATIN AMERICA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 335 TABLE 567 LATIN AMERICA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 335 TABLE 568 LATIN AMERICA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 335 TABLE 569 LATIN AMERICA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 336 TABLE 570 LATIN AMERICA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 336 TABLE 571 LATIN AMERICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 336 TABLE 572 LATIN AMERICA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 337 TABLE 573 LATIN AMERICA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 337 TABLE 574 LATIN AMERICA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 337 TABLE 575 LATIN AMERICA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 338 TABLE 576 LATIN AMERICA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 338 TABLE 577 LATIN AMERICA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 339 TABLE 578 BRAZIL: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 339 TABLE 579 BRAZIL: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 340 TABLE 580 BRAZIL: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 340 TABLE 581 BRAZIL: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 340 TABLE 582 BRAZIL: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 341 TABLE 583 BRAZIL: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 341 TABLE 584 BRAZIL: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 341 TABLE 585 BRAZIL: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 342 TABLE 586 BRAZIL: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 342 TABLE 587 BRAZIL: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 342 TABLE 588 BRAZIL: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 343 TABLE 589 BRAZIL: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 343 TABLE 590 MEXICO: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 344 TABLE 591 MEXICO: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 344 TABLE 592 MEXICO: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 345 TABLE 593 MEXICO: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 345 TABLE 594 MEXICO: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 345 TABLE 595 MEXICO: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 346 TABLE 596 MEXICO: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 346 TABLE 597 MEXICO: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 346 TABLE 598 MEXICO: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 347 TABLE 599 MEXICO: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 347 TABLE 600 MEXICO: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 347 TABLE 601 MEXICO: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 348 TABLE 602 REST OF LATIN AMERICA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 349 TABLE 603 REST OF LATIN AMERICA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 349 TABLE 604 REST OF LATIN AMERICA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 349 TABLE 605 REST OF LATIN AMERICA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 350 TABLE 606 REST OF LATIN AMERICA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 350 TABLE 607 REST OF LATIN AMERICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 350 TABLE 608 REST OF LATIN AMERICA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 351 TABLE 609 REST OF LATIN AMERICA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 351 TABLE 610 REST OF LATIN AMERICA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 351 TABLE 611 REST OF LATIN AMERICA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 352 TABLE 612 REST OF LATIN AMERICA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 352 TABLE 613 REST OF LATIN AMERICA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 353 TABLE 614 MIDDLE EAST: KEY MACROINDICATORS 354 TABLE 615 MIDDLE EAST: CELL COUNTING MARKET, BY REGION, 2022–2029 (USD MILLION) 354 TABLE 616 MIDDLE EAST: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 354 TABLE 617 MIDDLE EAST: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 355 TABLE 618 MIDDLE EAST: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 355 TABLE 619 MIDDLE EAST: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 356 TABLE 620 MIDDLE EAST: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 356 TABLE 621 MIDDLE EAST: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 356 TABLE 622 MIDDLE EAST: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 357 TABLE 623 MIDDLE EAST: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 357 TABLE 624 MIDDLE EAST: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 357 TABLE 625 MIDDLE EAST: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 358 TABLE 626 MIDDLE EAST: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 358 TABLE 627 MIDDLE EAST: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 359 TABLE 628 GCC COUNTRIES: CELL COUNTING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 360 TABLE 629 GCC COUNTRIES: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 360 TABLE 630 GCC COUNTRIES: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 360 TABLE 631 GCC COUNTRIES: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 361 TABLE 632 GCC COUNTRIES: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 361 TABLE 633 GCC COUNTRIES: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 362 TABLE 634 GCC COUNTRIES: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 362 TABLE 635 GCC COUNTRIES: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 362 TABLE 636 GCC COUNTRIES: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 363 TABLE 637 GCC COUNTRIES: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 363 TABLE 638 GCC COUNTRIES: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 363 TABLE 639 GCC COUNTRIES: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 364 TABLE 640 GCC COUNTRIES: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 364 TABLE 641 SAUDI ARABIA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 365 TABLE 642 SAUDI ARABIA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 366 TABLE 643 SAUDI ARABIA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 366 TABLE 644 SAUDI ARABIA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 367 TABLE 645 SAUDI ARABIA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 367 TABLE 646 SAUDI ARABIA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 367 TABLE 647 SAUDI ARABIA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 368 TABLE 648 SAUDI ARABIA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 368 TABLE 649 SAUDI ARABIA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 368 TABLE 650 SAUDI ARABIA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 369 TABLE 651 SAUDI ARABIA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 369 TABLE 652 SAUDI ARABIA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 370 TABLE 653 UAE: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 371 TABLE 654 UAE: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 371 TABLE 655 UAE: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 371 TABLE 656 UAE: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 372 TABLE 657 UAE: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 372 TABLE 658 UAE: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 372 TABLE 659 UAE: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 373 TABLE 660 UAE: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 373 TABLE 661 UAE: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 373 TABLE 662 UAE: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 374 TABLE 663 UAE: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 374 TABLE 664 UAE: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 375 TABLE 665 REST OF GCC COUNTRIES: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 376 TABLE 666 REST OF GCC COUNTRIES: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 376 TABLE 667 REST OF GCC COUNTRIES: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 376 TABLE 668 REST OF GCC COUNTRIES: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 377 TABLE 669 REST OF GCC COUNTRIES: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 377 TABLE 670 REST OF GCC COUNTRIES: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 377 TABLE 671 REST OF GCC COUNTRIES: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 378 TABLE 672 REST OF GCC COUNTRIES: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 378 TABLE 673 REST OF GCC COUNTRIES: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 378 TABLE 674 REST OF GCC COUNTRIES: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 379 TABLE 675 REST OF GCC COUNTRIES: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 379 TABLE 676 REST OF GCC COUNTRIES: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 380 TABLE 677 REST OF MIDDLE EAST: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 381 TABLE 678 REST OF MIDDLE EAST: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 381 TABLE 679 REST OF MIDDLE EAST: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 382 TABLE 680 REST OF MIDDLE EAST: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 382 TABLE 681 REST OF MIDDLE EAST: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 383 TABLE 682 REST OF MIDDLE EAST: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 383 TABLE 683 REST OF MIDDLE EAST: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 383 TABLE 684 REST OF MIDDLE EAST: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 384 TABLE 685 REST OF MIDDLE EAST: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 384 TABLE 686 REST OF MIDDLE EAST: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 384 TABLE 687 REST OF MIDDLE EAST: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 385 TABLE 688 REST OF MIDDLE EAST: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 385 TABLE 689 AFRICA: KEY MACROINDICATORS 387 TABLE 690 AFRICA: CELL COUNTING MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 387 TABLE 691 AFRICA: CELL COUNTING CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION) 387 TABLE 692 AFRICA: CELL COUNTING ASSAY KITS MARKET, BY TYPE, 2022–2029 (USD MILLION) 388 TABLE 693 AFRICA: CELL COUNTING INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION) 388 TABLE 694 AFRICA: CELL COUNTING SPECTROPHOTOMETERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 388 TABLE 695 AFRICA: CELL COUNTING HEMATOLOGY ANALYZERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 389 TABLE 696 AFRICA: CELL COUNTERS MARKET, BY MODE, 2022–2029 (USD MILLION) 389 TABLE 697 AFRICA: CELL COUNTERS MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 389 TABLE 698 AFRICA: CELL COUNTING MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 390 TABLE 699 AFRICA: CELL COUNTING RESEARCH APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 390 TABLE 700 AFRICA: CELL COUNTING MEDICAL APPLICATIONS MARKET, BY TYPE, 2022–2029 (USD MILLION) 390 TABLE 701 AFRICA: CELL COUNTING MARKET, BY END USER, 2022–2029 (USD MILLION) 391 TABLE 702 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN CELL COUNTING MARKET, 2021–2025 393 TABLE 703 CELL COUNTING MARKET: DEGREE OF COMPETITION 396 TABLE 704 CELL COUNTING MARKET: REGION FOOTPRINT 403 TABLE 705 CELL COUNTING MARKET: PRODUCT FOOTPRINT 404 TABLE 706 CELL COUNTING MARKET: APPLICATION FOOTPRINT 405 TABLE 707 CELL COUNTING MARKET: DETAILED LIST OF KEY STARTUPS/SMES 408 TABLE 708 CELL COUNTING MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 409 TABLE 709 CELL COUNTING MARKET: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 410 TABLE 710 CELL COUNTING MARKET: DEALS, JANUARY 2021–JANUARY 2025 411 TABLE 711 CELL COUNTING MARKET: EXPANSIONS, JANUARY 2021–JANUARY 2025 412 TABLE 712 DANAHER CORPORATION: COMPANY OVERVIEW 413 TABLE 713 DANAHER CORPORATION: PRODUCTS OFFERED 415 TABLE 714 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 419 TABLE 715 DANAHER CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 419 TABLE 716 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 421 TABLE 717 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 423 TABLE 718 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2021–JANUARY 2025 425 TABLE 719 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 427 TABLE 720 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 429 TABLE 721 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2021–JANUARY 2025 433 TABLE 722 BD: COMPANY OVERVIEW 435 TABLE 723 BD: PRODUCTS OFFERED 437 TABLE 724 BD: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 440 TABLE 725 ABBOTT LABORATORIES: COMPANY OVERVIEW 442 TABLE 726 ABBOTT LABORATORIES: PRODUCTS OFFERED 444 TABLE 727 MERCK KGAA: COMPANY OVERVIEW 446 TABLE 728 MERCK KGAA: PRODUCTS OFFERED 448 TABLE 729 MERCK KGAA: DEALS, JANUARY 2021–JANUARY 2025 450 TABLE 730 MERCK KGAA: EXPANSIONS, JANUARY 2021–JANUARY 2025 450 TABLE 731 REVVITY: COMPANY OVERVIEW 451 TABLE 732 REVVITY: PRODUCTS OFFERED 453 TABLE 733 REVVITY: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 456 TABLE 734 REVVITY: DEALS, JANUARY 2021–JANUARY 2025 456 TABLE 735 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 457 TABLE 736 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 459 TABLE 737 CORNING INCORPORATED: COMPANY OVERVIEW 463 TABLE 738 CORNING INCORPORATED: PRODUCTS OFFERED 465 TABLE 739 TECAN TRADING AG: COMPANY OVERVIEW 467 TABLE 740 TECAN TRADING AG: PRODUCTS OFFERED 469 TABLE 741 BOULE: COMPANY OVERVIEW 470 TABLE 742 BOULE: PRODUCTS OFFERED 472 TABLE 743 BOULE: DEALS, JANUARY 2021–JANUARY 2025 473 TABLE 744 HORIBA: COMPANY OVERVIEW 474 TABLE 745 HORIBA: PRODUCTS OFFERED 476 TABLE 746 HORIBA: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 477 TABLE 747 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW 478 TABLE 748 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 480 TABLE 749 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 481 TABLE 750 EVIDENT: COMPANY OVERVIEW 482 TABLE 751 EVIDENT: PRODUCTS OFFERED 482 TABLE 752 EVIDENT: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 484 TABLE 753 EVIDENT: DEALS, JANUARY 2021–JANUARY 2025 484 TABLE 754 EVIDENT: EXPANSIONS, JANUARY 2021–JANUARY 2025 484 TABLE 755 F. HOFFMANN-LA ROCHE LTD: COMPANY OVERVIEW 485 TABLE 756 F. HOFFMANN-LA ROCHE LTD: PRODUCTS OFFERED 487 TABLE 757 SYSMEX CORPORATION: COMPANY OVERVIEW 488 TABLE 758 SYSMEX CORPORATION: PRODUCTS OFFERED 489 TABLE 759 SYSMEX CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025 491 TABLE 760 SYSMEX CORPORATION: DEALS, JANUARY 2021–JANUARY 2025 492 TABLE 761 CYTEK BIOSCIENCES: COMPANY OVERVIEW 493 TABLE 762 TIP BIOSYSTEMS: COMPANY OVERVIEW 494 TABLE 763 ALIGNED GENETICS: COMPANY OVERVIEW 495 TABLE 764 YOKOGAWA ELECTRIC CORPORATION: COMPANY OVERVIEW 496 TABLE 765 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW 497 TABLE 766 MILTENYI BIOTEC: COMPANY OVERVIEW 498 TABLE 767 LONZA: COMPANY OVERVIEW 499 TABLE 768 BIOLINE TECHNOLOGIES: COMPANY OVERVIEW 500 TABLE 769 NIKON CORPORATION: COMPANY OVERVIEW 501 TABLE 770 AXION BIOSYSTEMS, INC.: COMPANY OVERVIEW 502 TABLE 771 CREATIVE BIOARRAY: COMPANY OVERVIEW 503 FIGURE 1 CELL COUNTING MARKET SEGMENTATION 47 FIGURE 2 CELL COUNTING MARKET: RESEARCH DESIGN 51 FIGURE 3 CELL COUNTING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS 53 FIGURE 4 CELL COUNTING MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 54 FIGURE 5 CELL COUNTING MARKET ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 55 FIGURE 6 ILLUSTRATIVE EXAMPLE OF DANAHER CORPORATION: REVENUE SHARE ANALYSIS (2023) 56 FIGURE 7 SEGMENTAL MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 57 FIGURE 8 CELL COUNTING MARKET: CAGR PROJECTIONS 58 FIGURE 9 DATA TRIANGULATION METHODOLOGY 60 FIGURE 10 CELL COUNTING MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 63 FIGURE 11 CELL COUNTING MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 64 FIGURE 12 CELL COUNTING MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 64 FIGURE 13 GEOGRAPHICAL SNAPSHOT OF CELL COUNTING MARKET 65 FIGURE 14 INCREASING DEMAND FOR CELL-BASED RESEARCH TO DRIVE MARKET 66 FIGURE 15 RESEARCH APPLICATIONS DOMINATED NORTH AMERICAN MARKET IN 2023 67 FIGURE 16 ACADEMIC & RESEARCH INSTITUTES TO DOMINATE MARKET DURING FORECAST PERIOD 67 FIGURE 17 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 68 FIGURE 18 CELL COUNTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 69 FIGURE 19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73 FIGURE 20 AVERAGE SELLING PRICE TREND OF PRODUCTS, BY KEY PLAYER, 2022–2024 76 FIGURE 21 AVERAGE SELLING PRICE OF PRODUCTS, BY REGION, 2024 77 FIGURE 22 CELL COUNTING MARKET: SUPPLY CHAIN ANALYSIS 78 FIGURE 23 CELL COUNTING MARKET: VALUE CHAIN ANALYSIS 80 FIGURE 24 CELL COUNTING MARKET: ECOSYSTEM ANALYSIS 82 FIGURE 25 FUNDING ESTIMATES FOR STEM CELL RESEARCH, 2019–2025 85 FIGURE 26 CELL COUNTING MARKET: PATENT ANALYSIS, 2014−2024 88 FIGURE 27 CELL COUNTING MARKET: PORTER’S FIVE FORCES ANALYSIS 98 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 100 FIGURE 29 KEY BUYING CRITERIA FOR CELL COUNTING PRODUCTS, BY END USER 101 FIGURE 30 NORTH AMERICA: CELL COUNTING MARKET SNAPSHOT 245 FIGURE 31 US: FUNDING BY NATIONAL INSTITUTES OF HEALTH, 2014–2024 251 FIGURE 32 ASIA PACIFIC: CELL COUNTING MARKET SNAPSHOT 298 FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN CELL COUNTING MARKET, 2019–2023 395 FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN CELL COUNTING MARKET, 2023 396 FIGURE 35 EV/EBITDA OF KEY VENDORS, 2025 397 FIGURE 36 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 398 FIGURE 37 CELL COUNTING MARKET: BRAND/PRODUCT COMPARISON (CELL COUNTERS) 399 FIGURE 38 CELL COUNTING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 401 FIGURE 39 CELL COUNTING MARKET: COMPANY FOOTPRINT 402 FIGURE 40 CELL COUNTING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 407 FIGURE 41 DANAHER CORPORATION: COMPANY SNAPSHOT (2023) 414 FIGURE 42 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023) 422 FIGURE 43 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023) 428 FIGURE 44 BD: COMPANY SNAPSHOT (2024) 436 FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023) 443 FIGURE 46 MERCK KGAA: COMPANY SNAPSHOT (2023) 447 FIGURE 47 REVVITY: COMPANY SNAPSHOT (2023) 452 FIGURE 48 BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT (2023) 458 FIGURE 49 CORNING INCORPORATED: COMPANY SNAPSHOT (2023) 464 FIGURE 50 TECAN TRADING AG: COMPANY SNAPSHOT (2023) 468 FIGURE 51 BOULE: COMPANY SNAPSHOT (2023) 471 FIGURE 52 HORIBA: COMPANY SNAPSHOT (2023) 475 FIGURE 53 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023) 479 FIGURE 54 F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT (2023) 486 FIGURE 55 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023) 489

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們